Exaggerated renal pathology of partial ablation-induced chronic renal failure in eNOS deficient mice

Chika Yamashita1, Naoko Tazawa, Mamoru Ohkita

  • 1Laboratory of Pathological and Molecular Pharmacology, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan.

Insights

Endothelial nitric oxide synthase (eNOS) deficiency worsens chronic renal failure in mice, increasing mortality and kidney damage. eNOS-derived nitric oxide (NO) appears protective against kidney injury in this model.

Area of Science:

  • Nephrology
  • Cardiovascular Research
  • Molecular Biology

Background:

  • Chronic renal failure (CRF) is a significant health concern.
  • Endothelial nitric oxide synthase (eNOS) plays a crucial role in vascular health.
  • The specific role of eNOS in CRF progression is not fully understood.

Purpose of the Study:

  • To investigate the role of eNOS in a 5/6 nephrectomy remnant kidney model of CRF.
  • To compare renal injury and survival rates between eNOS-deficient and wild-type mice.

Main Methods:

  • Utilized eNOS-deficient (eNOS-/-) and wild-type mice.
  • Induced chronic renal failure using a 5/6 nephrectomy surgical model.
  • Monitored blood urea nitrogen, plasma creatinine, proteinuria, survival rates, and glomerular size over 8 weeks.

Main Results:

  • Both wild-type and eNOS-/- mice showed increased blood urea nitrogen, creatinine, and proteinuria post-nephrectomy.
  • These changes were significantly more pronounced in eNOS-/- mice.
  • Survival rate was drastically lower in eNOS-/- mice (23%) compared to wild-type mice (69%).
  • Glomeruli in nephrectomized eNOS-/- mice tended to be larger than in wild-type counterparts.

Conclusions:

  • eNOS-derived nitric oxide (NO) appears to have a protective effect against renal injury in the remnant kidney model.
  • eNOS deficiency exacerbates the progression of chronic renal failure and reduces survival.

Related Concept Videos